Rufus Mitchell-Heggs is the Co-founder & Chief Scientific Officer of Connectome - a neurotechnology company transforming how we understand and optimise the human brain.

Connectome’s mission is to make advanced brain insights accessible to everyone, starting with a non-invasive scan, and over time building the world’s largest longitudinal brain dataset.

In this episode, we discuss how Rufus and his team are focused on:

1. Only providing metrics that people can act on

2. The surprising customer segment raving about this technology

3. Balancing the tension between ‘moving fast and breaking things’ with ‘doing things properly’

You will also get to see Rufus demoing the headset himself!

If you’d like to participate in Connectome’s upcoming:

• Study at Imperial College London, you can sign up to their waitlist here.

• Round of fundraising, feel free to reach out to Rufus directly on LinkedIn.

Access the MindTech Matrix⁠ - see where Connectome sits on the first and only map of mind health technology startups organised by the problem they’re solving and the solution they’re building.

Links mentioned in the podcast episode:

• ⁠Neurotechnology Funding Snapshot (2024)⁠

• ⁠40% of Dementia Cases are Preventable⁠

• ⁠Biomarkers: What Makes One Great?⁠

• ⁠It Takes an Average of 17 Years for Evidence to Change Practice⁠